Scientists at the University of Cambridge in England studying the HCN2 gene, which is expressed in pain-sensitive nerve endings, have published their findings in the journal Science.
Engineering the removal of the HCN2 gene from pain-sensitive nerves in mice, researchers carried out studies using electrical stimuli on these nerves in cell cultures to determine how their properties were affected.
Related Articles on Chronic Pain:
Evidence Found on how Meditation Relieves Pain
FDA Approves Tapentadol for Chronic Pain
New Form of Nasal Administration Could Improve Response to Pain Drugs
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.